Ataxia telangiectasia mutated (ATM), could it be another useful biomarker for the successful treatment with the poly (ADP-ribose) polymerase inhibitor?

  • Suk Young Lee
  • , Sang Cheul Oh*
    • *Corresponding author for this work

    Research output: Contribution to journal › Editorial › peer-review

    1   Link opens in a new tab Citation (Scopus)

    Fingerprint

    Dive into the research topics of 'Ataxia telangiectasia mutated (ATM), could it be another useful biomarker for the successful treatment with the poly (ADP-ribose) polymerase inhibitor?'. Together they form a unique fingerprint.
    Sort by